A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas

NCT00909402 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Stomach Neoplasms
Esophageal Neoplasms

Interventions

DRUG: BMS-833923
DRUG: Cisplatin
DRUG: Capecitabine

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]